EP Patent

EP2554159A1 — Dosage forms comprising apixaban and content uniformity enhancer

Assigned to Ratiopharm GmbH · Expires 2013-02-06 · 13y expired

What this patent protects

The invention relates to compositions and/or oral dosage forms comprising micronized apixaban and a content uniformity enhancer. The invention also relates to methods of preparing said dosage forms.

USPTO Abstract

The invention relates to compositions and/or oral dosage forms comprising micronized apixaban and a content uniformity enhancer. The invention also relates to methods of preparing said dosage forms.

Drugs covered by this patent

Patent Metadata

Patent number
EP2554159A1
Jurisdiction
EP
Classification
—
Expires
2013-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Ratiopharm GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.